Revive Therapeutics Ltd.

OTCPK:RVVT.F Stock Report

Market Cap: US$2.9m

Revive Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

OTCPK:RVVT.F Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
10 Jul 24BuyUS$3,670Andrew LindzonIndividual333,000US$0.011
03 Jul 24BuyUS$3,669Michael FrankIndividual500,000US$0.0073
19 Mar 24BuyUS$2,580Michael FrankIndividual100,000US$0.026
18 Mar 24BuyUS$3,876Michael FrankIndividual150,000US$0.026
15 Mar 24BuyUS$7,139Michael FrankIndividual322,000US$0.022

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of RVVT.F?
Owner TypeNumber of SharesOwnership Percentage
Institutions25,0000.00597%
Individual Insiders6,952,5341.66%
General Public411,586,73598.3%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 16.8%.

Top Shareholders

Top 6 shareholders own 1.67% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
0.75%
Michael Frank
3,138,500US$21.7k0%no data
0.48%
Christian Scovenna
2,000,000US$13.8k0%no data
0.16%
William Jackson
650,000US$4.5k0%no data
0.15%
Joshua Herman
625,334US$4.3k0%no data
0.13%
Andrew Lindzon
538,700US$3.7k0%no data
0.006%
MAI Capital Management, LLC
25,000US$173.00%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/03 01:04
End of Day Share Price 2025/01/03 00:00
Earnings2024/09/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Revive Therapeutics Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Doug CooperBeacon Securities Limited